Literature DB >> 27082113

Influence of Socio-Economic Inequalities on Access to Renal Transplantation and Survival of Patients with End-Stage Renal Disease.

Wahida Kihal-Talantikite1, Cécile Vigneau2,3, Séverine Deguen1, Muriel Siebert2, Cécile Couchoud4, Sahar Bayat5.   

Abstract

BACKGROUND: Public and scientific concerns about the social gradient of end-stage renal disease and access to renal replacement therapies are increasing. This study investigated the influence of social inequalities on the (i) access to renal transplant waiting list, (ii) access to renal transplantation and (iii) patients' survival.
METHODS: All incident adult patients with end-stage renal disease who lived in Bretagne, a French region, and started dialysis during the 2004-2009 period were geocoded in census-blocks. To each census-block was assigned a level of neighborhood deprivation and a degree of urbanization. Cox proportional hazards models were used to identify factors associated with each study outcome.
RESULTS: Patients living in neighborhoods with low level of deprivation had more chance to be placed on the waiting list and less risk of death (HR = 1.40 95%CI: [1.1-1.7]; HR = 0.82 95%CI: [0.7-0.98]), but this association did not remain after adjustment for the patients' clinical features. The likelihood of receiving renal transplantation after being waitlisted was not associated with neighborhood deprivation in univariate and multivariate analyses.
CONCLUSIONS: In a mixed rural and urban French region, patients living in deprived or advantaged neighborhoods had the same chance to be placed on the waiting list and to undergo renal transplantation. They also showed the same mortality risk, when their clinical features were taken into account.

Entities:  

Mesh:

Year:  2016        PMID: 27082113      PMCID: PMC4833352          DOI: 10.1371/journal.pone.0153431

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Renal transplantation is the optimal treatment for end-stage renal disease (ESRD). It is associated with increased quality of life [1,2], lower mortality and morbidity [3-5]. In developed countries, many studies found that age, gender and comorbidities [6,7] are associated with access to the renal transplant waiting list [8,9] and mortality [10]. Moreover, social inequalities in the access to the transplant waiting lists and to renal transplantation have been highlighted in the United States of America (USA) and United Kingdom (UK). These disparities may be related to several individual and neighborhood-related factors. Specifically, some works suggested a role for various non-medical individual factors, such as health insurance status [11], employment status [12] and education level [13]. Previous epidemiological studies also showed a social gradient of ESRD [14,15] and access to the transplant waiting list [16-19]. Indeed, people living in deprived neighborhoods are more likely to start renal replacement therapy and less likely to be wait-listed. However, the results of studies on access to renal transplantation after being waitlisted and on patients’ survival are contradictory [8,16]. The meta-analysis carried out by Morton et al. found consistent evidences that disadvantaged individuals with chronic kidney disease (CKD) have poorer access to quality treatment, including renal transplantation [20]. Studies in the USA suggest that the socio-economic status is a potential determinant of access to health care [21] that can influence the likelihood of placement on the renal transplant waiting list and of renal transplantation. In France, the access to diagnosis could be affected by neighborhood deprivation [22]; however, the national health insurance system covers the entire population and, therefore, ESRD treatment should not be limited by the patients’ socio-economic status. Moreover, medical and hospital costs for patients with CKD are completely covered (100%) and the reimbursement is regulated according to uniform rates, regardless of whether the patient is treated in public or private-sector nephrology facilities. To our knowledge, few studies have investigated the impact of both patients’ medical features and non-medical contextual factors on the access to the renal transplant waiting list, renal transplantation and patients’ survival. These works assessed the influence of individual or neighborhood-related factors (deprivation, or degree of urbanization) on renal transplantation or on survival. However, most of them focused on racial disparities and investigated mainly the effect of poverty on these disparities [18,23]. In France, no study has assessed the social inequalities of access to renal transplantation. After a study on the socio-spatial inequalities of ESRD incidence in Bretagne [22], here we investigated the social inequalities in (i) the access to the renal transplant waiting list, (ii) access to renal transplantation after being wait-listed and (iii) patients’ survival, by taking into account both individual and neighborhood characteristics (neighborhood deprivation and degree of urbanization) of the smallest geographic unit (census block), in Bretagne, a French region.

Material and Methods

Study setting

This study was carried out in Bretagne, one of the administrative regions in France. Bretagne is a mixed urban and rural region, located in the western part of France, with a population of 3,094,000 inhabitants in 2006.

Data source and participants’ selection

This study included a cohort of adult patients who lived in Bretagne and started dialysis (incident cases) between January 1, 2004 and December 31, 2009. This cohort was extracted from the French national “Réseau Epidémiologie et Information en Néphrologie” (REIN) registry [24,25]. The patients’ residential address was retrieved and matched to the corresponding census block. Preemptively transplanted patients were not included.

Covariates

Five categories of variables were studied: Demographic data: age group (18–39, 40–59, 60–69, ≥70 years), sex and occupational status. Clinical features at first dialysis: body mass index (BMI), hemoglobin and serum albumin, primary renal disease (categorized in six groups: glomerulonephritis, pyelonephritis, diabetic nephropathy, hypertensive and vascular nephropathy, polycystic kidney disease and other causes/unknown) and comorbidities. The Comorbidities included in this analysis were: cardiovascular disease (coronary artery disease, peripheral vascular disease, congestive heart failure, arrhythmia, aortic aneurysm and cerebrovascular disease), diabetes, chronic respiratory disease, hepatic disease, active malignancy and physical disabilities (physical impairment of ambulation, para- or hemiplegia, blindness, member amputation). Data concerning the medical follow-up in nephrology centers: ownership of nephrology facility where the first dialysis was performed (public university centers, public non-university centers and private centers), date of first dialysis, emergency vs planned first dialysis session, type of first dialysis (hemodialysis (HD) or peritoneal dialysis (PD)), date of placement on the waiting list, date of renal transplantation and date of death. Blood type and Panel Reactive Antibody (PRA) for patients registered on the waiting list and donor type (deceased or living) for patients who underwent renal transplantation. Two neighborhood characteristics at the census-block level: (i) degree of urbanization (rural/ urban typology) and (ii) socio-economic deprivation index. The residential census block of each patient was classified as urban or rural [22] using an approach inspired from the study by Van Eupene al., 2012 [26]. The urban/rural typology was defined by combining two criteria of rural/urban classification: the population density, using the OECD typology (Organization for Economic Co-operation and Development) [27] and land cover [28] (for more details, see Kihal et al., 2015 [22]). For the socio-economic deprivation index, socio-economic and demographic data were obtained from the 2006 census at the census-block level. To characterize the neighborhood deprivation level, a deprivation index was used that included variables related to education, income, occupation, unemployment and immigration to cover and capture the different dimensions of deprivation. Successive principal-component analyses were performed to calculate the deprivation index, based on Lalloue et al. [29], in each considered geographic area (rural/urban). The measure of neighborhood deprivation was categorized in three groups (low, moderate or high deprivation) according to the tertiles of the index distribution [22].

Outcomes measures

The outcomes of interest included: Access to the renal transplant waiting list: patients placed on the waiting list before starting dialysis were considered to be wait-listed at first dialysis. Time to wait-listing was calculated from the date of first dialysis. Not wait-listed patients were censored at the date of death or at the end of the follow-up period (December 31, 2011). Access to renal transplantation after placement on the list: patients who received renal transplant from a living donor were excluded from the analyses. Time to renal transplantation was calculated from the date of placement on the waiting list. Non-transplanted patients were censored at the date of death or at the end of the follow-up period. Survival: time to death was calculated from the date of the first dialysis. Living patients were censored at the end of the follow-up period. Renal transplantation was considered as a time- dependent covariate.

Statistical analyses

Cox proportional hazards models were used to identify the factors associated with the likelihood of (i) being placed on the waiting list, (ii) being transplanted after placement on the waiting list and (iii) survival. Patients with missing data were excluded from the analyses. First, univariate Cox regression analyses were performed to assess associations between the outcomes and the patients’ characteristics (including neighborhood data). Then, multivariate Cox models were constructed using variables with a p-value lower than 0.2 in univariate analyses and variables that were selected a priori, based on literature findings (gender and neighborhood deprivation). Results were reported as hazard ratios (HR) with 95% confidence interval (CI) and p-values. Statistical significance was identified by a p-value lower than 0.05. All analyses were performed using the STATA software (version11.2).

Ethics statement

This retrospective study was approved by the French Biomedecine Agency and included patients’ data that were anonymized and de-identified directly in the REIN database before extraction for the analysis. Patients and the associated data were extracted from the French REIN registry that was approved by CNIL (Commission Nationale de l’Information et des Libertés) in 2010. REIN is registered with the CNIL under the following number: 903188 Version 3.

Results

Participants’ characteristics

Data concerning 2006 incident patients who lived in Bretagne and started dialysis between January 2004 and December 2009 were extracted from the REIN registry. By the end of 2011, 27% of them were registered on the transplant waiting list and 24% had received a kidney transplant mostly from deceased donors (five living donors). Moreover, 931 patients (46%) died during the follow-up period. Among the 2006 patients, 56.1% were older than 70 years (mean age: 67.3 years), 60.6% males, 79.1% without occupation, 26% had diabetes, 54.5% had cardiovascular diseases, 47.2% lived in a rural area, 50% in census-blocks with high socio-economic deprivation and 18.7% in areas with low deprivation (Table 1).
Table 1

Patients’ characteristics at first dialysis and their association with access to the waiting list (univariate and multivariate Cox analyses).

Patients’ characteristicsNumber (%)Univariate analysisMultivariate analysis
 2006HR (95%CI)p-valueHR (95%CI)p-value
Age   
18–39122 (6.1)54.52 [36.7–81.1]<0.00129.81 [18.1–49.1]<0.001
40–59425 (21.2)38.10 [24.4–54.9]<0.00123.50 [15.2–36.4]<0.001
60–69334 (16.6)12.15 [8.2–18.0]<0.00111.00 [7.01–17.2]<0.001
≥701125 (56.1)1 1 
Sex      
Men1216 (60.6)1.06 [0.9–1.2]0.491.01 [0.8–1.2]0.9
Women790 (39.4)1 1 
Occupational status     
Yes264 (14.3)8.38[7.0–10.2]<0.0011.61 [1.3–2.0]<0.001
No1587 (85.7)1 1 
BMI (kg/m2)     
<20262 (14)0.98 [0.7–1.3]0.87- 
[20–25[783 (41.8)1 - 
[25–30 [537 (28.7)0.85 [0.7–1.1]0.14- 
[30–35 [212 (11.3)1.02 [0.8–1.3]0.85- 
≥3579 (4.2)0.46 [0.3–0.8]0.008- 
Serum albumin (g/dl)     
<30347 (20.6)0.47 [0.3–0.6]<0.001- 
≥301334 (79.4)1   
Hemoglobin (g/dl)     
<10600 (32.7)1.04 [0.8–1.3]0.64- 
[10–12[879 (47.9)1 - 
≥12356 (19.4)1.31 [1.1–1.6]0.02- 
Type of dialysis     
HD1756 (87.5)0.85 [0.7–1.1]0.20- 
DP250 (12.5)1 - 
Emergency first dialysis session     
Yes558 (71.4)0.67 [0.5–0.8]<0.0010.59 [0.5–0.8]<0.001
No1393(28.6)1 1 
Ownership of dialysis facility     
Private791(39.4)2.16 [1.8–2.6]<0.0011.4 1[1.1–1.7]0.001
Public, non-university943(47.0)1 1 
Public, university272 (13.6)0.52 [0.4–0.8]0.0010.64 [0.4–1.0]0.06
Primary renal disease     
APKD 76 (3.8)1 1 
Hypertensive & vascular481 (24.0)0.14 [0.1–0.2]<0.0010.72 [0.5–1.0]0.07
Other & unknown786 (39.2)0.26 [0.2–0.3]<0.0010.62 [0.5–0.8]<0.001
Diabetes187 (9.3)0.25 [0.2–0.4]<0.0010.67 [0.4–0.98]0.04
Glomerulonephritis267 (13.3)0.64 [0.5–0.8]0.0010.85 [0.6–1.1]0.28
Pyelonephritis108 (5.4)0.59 [0.4–0.8]0.0030.77 [0.5–1.1]0.19
Cardiovascular disease     
Yes1058 (54.5)0.20 [0.2–0.3]0.0010.52 [0.4–0.7]<0.001
No883 (45.5)1 1 
Chronic respiratory disease     
Yes239 (87.5)0.38 [0.3–0.6]<0.001- 
No1668(12.5)1 - 
Active malignancy     
Yes217 (11.4)0.18 [0.1–0.3]<0.0010.28 [0.2–0.5]<0.001
No1689 (88.61 1 
Diabetes     
Yes505 (26.0)0.49 [0.4–0.6]<0.001- 
No1437 (74.0)1 - 
Physical disabilities     
Yes335 (17.6)0.18 [0.1–0.3]<0.0010.48 [0.3–0.8]0.002
No1566 (82.4)1 1 
Hepatic disease     
Yes1 832 (96.3)0.21 [0.1–0.5]0.0010.23 [0.1–0.6]<0.001
No70 (3.7)1 1 
Neighborhood deprivation     
Low75(18.7)1.40 [1.1–1.7]0.0021.04 [0.8–1.3]>0.5
Moderate628(31.3)1.06 [0.9–1.3]0.531.14 [0.9–1.4]0.7
High1003(50.0)1 1 
Degree of urbanization     
Rural946 (47.2)1 - 
Urban1060 (52.8)0.86 [0.7–1.0]0.09- 

† Body Mass Index

‡ polycystic kidney disease

HD: hemodialysis; PD: peritoneal dialysis

† Body Mass Index polycystic kidney disease HD: hemodialysis; PD: peritoneal dialysis Among the patients placed on the waiting list (n = 546), 5.9% were older than 70 years, 61.5% were males and 56.1% without occupation, 16.3% had diabetes, 21.6% had cardiovascular diseases, 50.7% lived in a rural area, 46.1% were from highly disadvantaged and 23.6% from less disadvantaged census-blocks.

Access to the renal transplant waiting list (Table 1)

(a) Univariate analysis

Occupation, young age, high hemoglobin level (≥12 g/dl) and private ownership of the nephrology facility were significantly associated with higher access to the transplant waiting list. The presence of co-morbidities, physical disabilities, low serum albumin level (<30 g/dl), high BMI value (≥35kg/m²), emergency first dialysis (vs planned one) and all primary renal diseases (compared with polycystic kidney disease) were significantly associated with a lower probability of being wait-listed. Patients living in less disadvantaged census-blocks had higher access to the waiting list than those living in highly disadvantaged areas. Similarly, access to the waiting list was higher for patients living in urban areas than for those living in rural census-blocks.

(b) Multivariate analysis

Young patients (18–39 years) were more likely to be placed on the waiting list (aHR = 29.81 95%CI: [18.1–49.1]). Patients with a cardiovascular disease, hepatic disease, active malignancy or physical disability were less likely to be placed on the list than patients without comorbidity (adjusted HR, aHR = 0.52 95%CI: [0.4–0.7]; aHR = 0.23 95%CI: [0.1–0.6]; aHR = 0.28 95%CI: [0.2–0.5]; aHR = 0.48 95%CI: [0.3–0.8], respectively). Similarly, emergency first dialysis session was still associated with a lower probability of being wait-listed (aHR = 0.59 95%CI: [0.5–0.8]). Patients followed in private facilities were 41% more likely to be registered on the waiting list than patients followed in public non university centers. Conversely, neighborhood deprivation was not significantly associated with access to the waiting list in multivariate analysis.

Access to deceased donor renal transplantation after being wait-listed (Table 2)

Patients aged ≥70 years or with the A or AB blood groups (compared with the O group) had higher access to renal transplantation. Conversely, the presence of diabetes and active malignancy at first dialysis, diabetic nephropathy (compared with polycystic kidney disease) and hyperimmunisation (PRA ≥85%) were associated with lower access to renal transplantation. Neighborhood deprivation and rural/urban typology were not significantly associated with access to renal transplantation. * Body Mass Index ** Polycystic kidney disease HD: hemodialysis; PD: peritoneal dialysis Patients aged ≥70 years (compared with the 18–39 year/old group) were 72% more likely to receive a transplant. Conversely, all clinical data at first dialysis, type of primary renal disease and type of first dialysis were no longer associated with the probability of undergoing transplantation. Among comorbidities, only cardiovascular diseases remained significantly associated with a lower probability of transplantation (aHR = 0.74 95%CI: [0.6–0.9]). Patients with A or AB blood group were still more likely (two times) to receive a kidney transplant than O group patients. Conversely, B blood group and high degree of immunization were associated with a lower probability of receiving a renal transplant (aHR = 0.70 95%CI: [0.5–0.9]; aHR = 0.57 95%CI: [0.4–0.93], respectively). After adjustment for the patients’ features, the likelihood of renal transplantation was not significantly different in the different socio-economic areas, although it was slightly lower for patients living in advantaged neighborhoods than for patients living in deprived areas (aHR = 0.86 95%CI: [0.7–1.1]).

Patients’ survival (Table 3)

Low BMI (<20 kg/m²), low serum albumin level (<30 g/dl), presence of comorbidities, physical disabilities, emergency first dialysis and all primary renal diseases (compared with polycystic kidney disease) were significantly associated with higher mortality risk. Compared with patients followed in public non university centers, the mortality risk was lower for patients followed in private centers and higher for those followed in public university facilities. Transplantation during the follow-up period was associated with lower mortality risk. Neighborhood deprivation was significantly associated with higher mortality; conversely, the degree of urbanization was not associated with the mortality risk. * Body Mass Index ** Polycystic kidney disease HD: hemodialysis; PD: peritoneal dialysis Patients aged between 18 and 39 (compared with the ≥70 year/old group) had a lower risk of death (aHR: 0.18[0.1–0.4]). Patients with a cardiovascular disease, respiratory disease, active malignancy, or physical disabilities had a higher mortality risk (aHR = 1.83 95%CI: [1.5–2.2]; aHR = 1.40 95%CI: [1.1–1.7]; aHR = 1.51 95%CI: [1.2–1.89]; aHR = 1.81 95%CI: [1.5–2.2], respectively). Low BMI values (<20 g/dl) were associated with higher probability of death (aHR = 1.43 95%CI: [1.0–1.8]). Transplantation during the follow-up period was associated with lower probability of death (aHR = 0.25 95%CI: [0.2–0.4]). After adjustment for the patients’ clinical features, the likelihood of mortality was no longer associated with neighborhood deprivation, although it was slightly lower among patients living in advantaged than among those living in deprived areas (aHR = 0.98 95%CI: [0.8–1.2]).

Discussion

This first contextual study in France on the role of socio-economic factors in the access to renal transplantation or patients’ survival shows that, after taking into account the patients’ clinical features, neighborhood deprivation and degree of urbanization are not associated with access to the renal transplant waiting list, transplantation after placement on the list or survival. To our knowledge, no other study on the access to renal transplantation has taken into account both patients’ clinical features and neighborhood characteristics (socio-economic level and urbanization degree) at a fine spatial level in mixed urban and rural areas. Indeed, most studies focused either on racial disparities or on poverty [18,23], without considering the urbanization degree [8,16,30,31]. Moreover, in contrast with previous reports from the USA, the UK and Scotland [8,19,32-37], our study took into account all major comorbidities. Although our univariate analysis showed that patients living in highly deprived neighborhoods had less chance to be placed on the waiting list, this association did not remain after taking into account other patients’ characteristics. In the USA [16-18,38] and in the UK [8,19], all studies found that patients living in a highly deprived neighborhood were less likely to be placed on the waiting list. Moreover, a higher social adaptability index (SAI) was associated with increased likelihood of being wait-listed [16]. Our findings show that the likelihood of renal transplantation after placement on the list and risk of death were slightly, but not significantly, lower among patients living in advantaged neighborhoods. Contradictory results were reported by previous epidemiological studies. Indeed, while some authors found that patients had an equal chance of transplantation, regardless of their socioeconomic status [8,39], others showed that patients living in advantaged neighborhoods had a greater likelihood of receiving a transplant [16,31]). Conversely, neighborhood poverty [40] or lower median income [17] was associated with a reduced probability of transplantation [17]). Another study found that neighborhoods with low level of deprivation were associated with reduced mortality risk [30] and that mortality was higher for patients living in the poorest areas [40] only among Asians and Pacific Islanders. On the other hand, another work reported that the risk of death was lower among patients living in deprived neighborhoods [31]. Overall, studies carried out in the USA and UK show that neighborhood deprivation plays an important role; conversely, our study suggests that neighborhood deprivation is not a determinant factor for receiving renal transplantation. These conflicting results may be due to health care system differences between the USA, the UK and France (universal health care system). Indeed, this finding is plausible because in France, the national health insurance system covers the entire population. Moreover, people living in deprived neighborhoods have often more comorbidities (diabetes, cardiovascular diseases…) and malnutrition. These factors can limit the access to the waiting list. Therefore, if the patient’s medical condition is not taken into account during the analysis, the neighborhood deprivation effect may in reality reflect the comorbidity influence [14]. In addition, neighborhood deprivation may be associated with nephrologists’ clinical practice patterns. Our study was performed in Bretagne where there are two transplantation centers. This might have reduced the bias related to clinical practice variations and increased the possibility to analyze factors directly related to patients. These conflicting results could also be partially explained by the use of different deprivation measures (composite indexes [31], SAI [16,30], Carstairs score [8] or Townsend [19], poverty level [18,38,40] and income level [17]) to study how the access to the waiting list and to kidney transplant is affected by socio-economic variables. In our work, we used a neighborhood deprivation index that included variables related to education, income, occupation, unemployment and immigration to cover different dimensions of deprivation in rural and urban settings. This deprivation index has been validated and previously used to demonstrate socio-economic gradients in the incidence of ESRD in Bretagne [22] and of infant mortality in Lyon [41,42]. The second main finding of our study is that the degree of urbanization, like the neighborhood socio-economic features, does not influence the access to the transplant waiting list, to transplantation after being wait-listed and patients’ survival. A few recent studies revealed conflicting results. A study found that the urbanization degree of the patient’s residence was not associated with the time on the waiting listing [38]. Conversely, other works have shown that the likelihood of placement on the list [43] and of transplantation [43] was slightly, but significantly higher for people living in rural areas than for those residing in urban areas. Studies in the USA found that white non-Hispanic and Native American patients living in rural areas were more likely to undergo transplantation than those living in urban areas [44]. Conversely, in Rotterdam, low urbanization grade significantly and negatively influenced the chance of living donor transplantation [39]. Our study has some limitations. Race/ethnic differences were not recorded in the French ESRD registry because the French legislation does not allow collecting this kind of information. Data about the individual socio-economic status and about individual preferences were not available and were thus not included in our analysis. However, we chose a fine geographical scale, designed to be as homogeneous as possible in terms of socio-economic characteristics. The census block homogeneity allowed minimizing the ecological bias and the results can be considered as close as possible to what can be observed at the individual level.

Conclusion

In this study, we assessed social inequalities at a fine scale in a mixed rural and urban French region. Our results show that, after taking into account all major patients’ clinical characteristics, patients living in deprived neighborhoods and those living in advantaged ones had the same chance to be placed on the waiting list, to be transplanted and the same mortality risk. In France where everybody is covered by the national health insurance, the association observed, in univariate analysis, between higher neighborhood deprivation and lower access to renal transplantation is more related to the patients’ clinical features than to socio-economic factors, or nephrologists’ clinical practices.
Table 2

Association between patients’ characteristics and access to renal transplantation after placement on the waiting list (univariate and multivariate Cox analyses).

Patients’ characteristicsNumber (%)Univariate analysisMultivariate analysis
 546HR (95%CI)p-valueHR (95%CI)p-value
Age  
18–39 104 (19.0)1 1 
40–59302 (55.3)1.00 [0.8–1.3]0.930.86 [0.7–1.1]0.16
60–69108 (19.8)1.04[0.8–1.4]0.740.89 [0.7–1.2]0.20
≥7032 (5.9)1.61[1.1–2.4]0.021.72 [1.1–2.6]0.01
Gender   
Men336 (61.5)1.01 [0.8–1.2]0.900.95 [0.8–1.2]0.71
Women210 (38.5)1 1 
Occupation status    
No281 (56.1)1   
Yes220 (43.9)1.12 [0.9–1.3]0.23  
Blood group   
O258 (47.3)1 1 
A207 (37.9)1.95 [1.6–2.4]<0.0012.17 [1.8–2.8]<0.001
B22 (4.0)0.69 [0.5-.0.9]0.020.70 [0.5–0.9]0.045
AB59 (10.8)2.08 [1.3–3.3]0.0021.89 [1.1–3.13]0.047
Panel Reactive Antibody (PRA)   
%<85525 (96.1)1 1 
≥8521 (3.9)0.63 [0.4–1.0]0.050.57 [0.4–0.93]0.027
BMI*(kg/m2)   
<2073 (13.9)0.83 [0.6–1.1]0.2- 
[20–25[232 (44.1)1 - 
[25–30 [141 (26.8)0.94 [0.7–1.2]0.61- 
[30–35 [67(12.7)0.78 [0.6–1.1]0.11- 
≥3513 (2.5)0.93 [0.5–1.7]0.81- 
Serum albumin (g/dl)   
<3052 (11.0)0.76 [0.5–1.1]0.09- 
≥30420 (89)1 - 
Hemoglobin (g/dl)   
<10163 (31.8)1.01 [0.8–1.3]0.85  
[10–12[232 (45.2)1   
≥12118 (23)0.93 [0.7–1.2]0.58  
Type of dialysis    
HD473 (86.6)0.88 [0.7–1.2]0.37  
DP73 (13.4)1   
Ownership of dialysis facility   
Private318 (58.2)1.17 [1.0–1.4]0.09- 
Public, non-university198 (36.3)1 - 
Public, university30 (5.5)1.33 [0.9–2.1]0.19- 
Emergency first dialysis session   
Yes115 (21.1)0.95 [0.8–1.2]0.67  
No423 (77.5)1   
Primary renal disease   
APKD**110 (20.2)1 - 
Hypertensive & vascular61 (11.2)1.03 [0.7–1.4]0.83- 
Other &unknown164 (30.0)0.71 [0.6–0.99]0.04- 
Diabetes41 (7.5)0.65 [0.4–0.98]0.04- 
Glomerulonephritis124 (22.7)0.91 [0.7–1.2]0.51- 
Pyelonephritis46 (8.4)0.98 [0.7–1.4]0.92- 
Cardiovascular disease   
Yes114 (21.6)0.84 [0.7–1.1]0.150.74 [0.6–0.9]0.017
No414 (78.4)1 1 
Chronic respiratory disease   
Yes28 (5.3)0.67 [0.43–1.0]0.07- 
No495(94.6)1 - 
Active malignancy    
Yes13 (2.5)0.46 [0.2–0.97]0.04- 
No504 (97.5)1 - 
Diabetes   
Yes86 (16.3)0.70 [0.5–0.9]0.01- 
No443 (83.7)1   
Physical disabilities   
Yes19 (3.6)0.58 [0.3–1.0]0.07 - 
No506 (96.4)1  - 
Hepatic disease   
Yes5 (1.0)0.72 [0.2–2.3]0.57  
No512 (99.0)1   
Neighborhood deprivation   
Low129 (23.6)0.88 [0.7–1.1]0.290.86 [0.7–1.1]0.26
Moderate165 (30.2)0.99 [0.8–1.2]0.951.03 [0.8–1.3]0.90
High252 (46.2)1 1 
Degree of urbanization   
Rural277(50.7)0.97 [0.8–1.2]0.76  
Urban269 (49.3)1   

* Body Mass Index

** Polycystic kidney disease

HD: hemodialysis; PD: peritoneal dialysis

Table 3

Association between patients’ characteristics at first dialysis and mortality (univariate and multivariate Cox analyses).

Patients’ characteristicsUnivariate analysisMultivariate analysis
 HR (95%CI)p-valueHR (95%CI)p-value
Age    
18–390.05 [0.0–0.1]<0.0010.18 [0.1–0.4]<0.001
40–590.18 [0.1–0.2]<0.0010.40 [0.3–0.5]<0.001
60–690.42 [0.3–0.5]<0.0010.47 [0.4–0.6]<0.001
> = 701 1 
Sex    
Men1.11 [0.98–1.3]0.091.1 [0.9–1.34]0.120
women1 1 
Occupation status    
Yes0.09 [0.06–0.15]<0.001--
No1   
BMI*(kg/m2)    
<201.27 [1.04–1.6]0.011.43 [1.-1.8]0.003
[20–25[1 1 
[25–30 [1.00 [0.8–1.2]0.920.90 [0.7–1.1]0.30
[30–35 [0.99 [0.8–1.2]0.960.87 [0.7–1.1]0.33
≥350.82 [0.6–1.0]0.330.63 [0.4–1.04]0.06
Serum albumin (g/dl)    
<301.80 [1.5–2.1]<0.0011.3 [1.1–1.6]0.003
≥301 1 
Hemoglobin (g/dl)    
<101.05 [0.9–1.2]0.48- 
[10–12[1 - 
≥120.83 [0.7–1.0]0.06- 
Type of dialysis     
HD0.82 [0.7–0.99]0.050.77 [0.6–0.96]0.026
DP1 1 
Emergency first dialysis session    
Yes1.31 [1.1–1.5]<0.001--
No1 - 
Renal transplantation    
Yes0.08 [0.05–0.1]<0.0010.25 [0.2–0.4]<0.001
No1 1 
Primary renal disease    
APKD**1 1 
Hypertensive & vascular5.38 [3.6–8.0]<0.0012.50 [1.5–4.17]<0.001
Other & unknown4.44 [3.0–6.6]<0.0012.70 [1.6–4.5]<0.001
Diabetes4.32 [2.8–6.6]<0.0012.64 [1.5–4.6]<0.001
Glomerulonephritis2.16 [1.4–3.3]<0.0011.72 [0.99–2.99]0.053
Pyelonephritis2.45 [1.5–4.0]<0.0012.32 [1.3–4.28]0.007
Ownership of dialysis facility  
Private0.64 [0.6–0.7]<0.001--
Public, non-university1--
Public university1.49 [1.2–1.8]<0.001--
Cardiovascular disease  
Yes3.40 [2.9–3.9]<0.0011.83 [1.5–2.2]<0.001
No1 1 
Chronic respiratory disease   
Yes1.76 [1.5–2.1]<0.0011.40 [1.1–1.7]0.002
No1 1 
Active malignancy    
Yes2.33[1.9–2.8]<0.0011.51 [1.2–1.89]<0.001
No1 1 
Diabetes    
Yes1.44[1.2–1.7]<0.001- 
No1 - 
Physical disabilities    
Yes2.94 [2.5–3.4]<0.0011.8 [1.5–2.2]<0.001
No1 1 
Hepatic disease    
Yes1.64 [1.2–2.2]0.001- 
No1 - 
Neighborhood deprivation    
Low0.82 [0.7–0.98]0.030.98 [0.8–1.24]0.9
Moderate1.02[0.9–1.2]0.731.13 [0.95–1.35]0.13
High1 1 
Degree of urbanization    
Urban1.06[0.9–1.2]0.35  
Rural1   

* Body Mass Index

** Polycystic kidney disease

HD: hemodialysis; PD: peritoneal dialysis

  41 in total

1.  Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease.

Authors:  Y N Hall; A M O'Hare; B A Young; E J Boyko; G M Chertow
Journal:  Am J Transplant       Date:  2008-09-19       Impact factor: 8.086

2.  Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.

Authors:  P P Garg; K D Frick; M Diener-West; N R Powe
Journal:  N Engl J Med       Date:  1999-11-25       Impact factor: 91.245

3.  Differences in access to cadaveric renal transplantation in the United States.

Authors:  R A Wolfe; V B Ashby; E L Milford; W E Bloembergen; L Y Agodoa; P J Held; F K Port
Journal:  Am J Kidney Dis       Date:  2000-11       Impact factor: 8.860

4.  Geographic variation in end-stage renal disease incidence and access to deceased donor kidney transplantation.

Authors:  A K Mathur; V B Ashby; R L Sands; R A Wolfe
Journal:  Am J Transplant       Date:  2010-04       Impact factor: 8.086

5.  Barriers to evaluation and wait listing for kidney transplantation.

Authors:  Jesse D Schold; Jon A Gregg; Jeffrey S Harman; Allyson G Hall; Pamela R Patton; Herwig-Ulf Meier-Kriesche
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-19       Impact factor: 8.237

6.  The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.

Authors:  Cécile Couchoud; Bénédicte Stengel; Paul Landais; Jean-Claude Aldigier; François de Cornelissen; Christian Dabot; Hervé Maheut; Véronique Joyeux; Michèle Kessler; Michel Labeeuw; Hubert Isnard; Christian Jacquelinet
Journal:  Nephrol Dial Transplant       Date:  2005-10-18       Impact factor: 5.992

7.  Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients.

Authors:  F K Port; R A Wolfe; E A Mauger; D P Berling; K Jiang
Journal:  JAMA       Date:  1993-09-15       Impact factor: 56.272

8.  Access to kidney transplantation among remote- and rural-dwelling patients with kidney failure in the United States.

Authors:  Marcello Tonelli; Scott Klarenbach; Caren Rose; Natasha Wiebe; John Gill
Journal:  JAMA       Date:  2009-04-22       Impact factor: 56.272

9.  Access to renal transplantation among American Indians and Hispanics.

Authors:  Thomas D Sequist; Andrew S Narva; Sharon K Stiles; Shelley K Karp; Alan Cass; John Z Ayanian
Journal:  Am J Kidney Dis       Date:  2004-08       Impact factor: 8.860

10.  Factors that influence access to the national renal transplant waiting list.

Authors:  Christopher R K Dudley; Rachel J Johnson; Helen L Thomas; Rommel Ravanan; David Ansell
Journal:  Transplantation       Date:  2009-07-15       Impact factor: 4.939

View more
  6 in total

1.  Social Deprivation Is Associated With Lower Access to Pre-emptive Kidney Transplantation and More Urgent-Start Dialysis in the Pediatric Population.

Authors:  Bénédicte Driollet; Florian Bayer; Theresa Kwon; Saoussen Krid; Bruno Ranchin; Michel Tsimaratos; Cyrielle Parmentier; Robert Novo; Gwenaelle Roussey; Stéphanie Tellier; Marc Fila; Ariane Zaloszyc; Astrid Godron-Dubrasquet; Sylvie Cloarec; Isabelle Vrillon; Françoise Broux; Etienne Bérard; Sophie Taque; Christine Pietrement; François Nobili; Vincent Guigonis; Ludivine Launay; Cécile Couchoud; Jérôme Harambat; Karen Leffondré
Journal:  Kidney Int Rep       Date:  2021-12-14

2.  Are There Inequities in Treatment of End-Stage Renal Disease in Sweden? A Longitudinal Register-Based Study on Socioeconomic Status-Related Access to Kidney Transplantation.

Authors:  Ye Zhang; Johan Jarl; Ulf-G Gerdtham
Journal:  Int J Environ Res Public Health       Date:  2017-01-27       Impact factor: 3.390

3.  Socioeconomic Inequalities in the Kidney Transplantation Process: A Registry-Based Study in Sweden.

Authors:  Ye Zhang; Ulf-G Gerdtham; Helena Rydell; Johan Jarl
Journal:  Transplant Direct       Date:  2018-02-02

4.  Associations between access to healthcare, environmental quality, and end-stage renal disease survival time: Proportional-hazards models of over 1,000,000 people over 14 years.

Authors:  Marissa B Kosnik; David M Reif; Danelle T Lobdell; Thomas Astell-Burt; Xiaoqi Feng; John D Hader; Jane A Hoppin
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

5.  Quantifying the Treatment Effect of Kidney Transplantation Relative to Dialysis on Survival Time: New Results Based on Propensity Score Weighting and Longitudinal Observational Data from Sweden.

Authors:  Ye Zhang; Ulf-G Gerdtham; Helena Rydell; Johan Jarl
Journal:  Int J Environ Res Public Health       Date:  2020-10-07       Impact factor: 3.390

6.  Living or deceased-donor kidney transplant: the role of psycho-socioeconomic factors and outcomes associated with each type of transplant.

Authors:  Abbas Basiri; Maryam Taheri; Alireza Khoshdel; Shabnam Golshan; Hamed Mohseni-Rad; Nasrin Borumandnia; Nasser Simforoosh; Mohsen Nafar; Majid Aliasgari; Mohammad Hossein Nourbala; Gholamreza Pourmand; Soudabeh Farhangi; Nastaran Khalili
Journal:  Int J Equity Health       Date:  2020-06-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.